Glucagon Series Sponsored by Xeris Pharmaceuticals, Inc. & Lilly Diabetes.  Blog 4: Alleviating Fears Associated with HyposDisclaimer: This blog is part of a series of blogs written by CDN students, alumni, and parents. CDN is committed to ensuring that young adults have the information they need to make informed choices about their healthcare. Given the recent innovations in glucagon, we wanted to highlight stories from our network about past experiences with lows, and how new treatment… Read more
Diabetes is never easy. It feels like that thing that’s constantly on your “to-do-list.” You can never seem to check it off; for some reason, it can’t be finished. One thing or another always seems to get in the way: you either get busy, tired…or forgetful from being busy and/or tired. It seems like a never-ending circle. A CGM (continuous glucose monitor), however, makes all of this just a little bit easier! It continuously monitors your glucose and shares all the data with the given reader.… Read more
In this new era of moving away from in-person medicine and transitioning to telehealth, when it comes to having diabetes and obtaining vital care, you may need some clarity on your options (pun intended). Continuous glucose monitors (CGMs) have been a revolutionary advancement in diabetes health management in recent years and have quickly been adapted into the lives of diabetics everywhere. This technology is ever-growing and expanding to meet the needs of its users. A lot of CGM’s offer… Read more
Glucagon Series Sponsored by Xeris Pharmaceuticals, Inc. & Lilly Diabetes.  Prompt: Blog 3: Student/Caregiver Relationship: As new rescue options emerge, the trust between us will grow. How does the risk of severe hypoglycemia affect your relationship with your caregiver?Disclaimer: This blog is part of a series of blogs written by CDN students, alumni, and parents. CDN is committed to ensuring that young adults have the information they need to make informed choices about their… Read more
I’m sitting on a small stool at my desk in my home office (my bedroom), wearing a dressy top and sweatpants, anxiously waiting for my Zoom call to start. My palms are sweaty, and I’ve nervously checked my Dexcom readings three times in the last five minutes. Professionally, I have worked with these calls daily since January of 2019. One might be wondering why this call is any different. This time, I was speaking with my PA-C care provider, whom I typically drive three hours to see in-person… Read more
It wasn’t until July 2013 – from inside of an emergency room – that I first heard of Type 1 diabetes (T1D). Being the first with the disease in my family, we did not understand what challenges we were beginning to face. It was not just about trying to keep your blood sugar down from hyperglycemia, it also involved taking the necessary measures to avoid a hypoglycemia. I did not understand the importance of hypoglycemia management until October 2018. After a hard day’s work of walking around the… Read more
After two hospitalizations, an out of control A1c, and 15 years of pumping, I knew I needed a change. My endocrinologist and I had discussed my options with my current pump and CGM. Although she encouraged me to stick with it, I knew I was burnt out. I decided to go back to the beginning of my diagnosis where I used multiple daily injections (MDI) to manage my diabetes. Unsurprisingly, like riding a bike, it all came back to me in an instant; my A1c dropped three points in three months as a… Read more
No, this is not some other type of condition. When I first heard the term “MDI”, I immediately thought of mesothelioma commercials. If you google MDI, various company and organizational names pop up. After a silly amount of research, I came to understand that MDI actually stands for Manual Daily Injections. Oh, duh, SHOTS! Being a person with type one diabetes for almost ten years, I have always heard interesting verbiage regarding diabetes and treatment methods. “Are you on the pump or shots… Read more
On August 15, 2016 I was diagnosed with type 1 diabetes (T1D). In the preceding three weeks I had lost 24 pounds, become fatigued, developed blurry vision, and somehow more frighteningly than anything else... the skin on my palms was peeling as though from a sunburn. At that time I was completely ignorant about diabetes. I didn’t know the difference between the two types, the causes, the relative genetic risks for each, or really anything else. I didn’t have the slightest idea how an insulin… Read more
Editors’ Note: MannKind Corp., the company which produces Afrezza, is a CDN Corporate Member. One of our CDN students who uses Afrezza as part of his diabetes management wrote this blog about his experience.  I was diagnosed with type 1 diabetes (T1D) the summer before my senior year of high school. Fast forward two years later, and I am still using the Novolog and Lantus pens I started out with. I am perfectly content with using insulin pens, and do not have much interest in trying a pump… Read more
Subscribe to Technology